The pharmaceutical industry in the United States is experiencing a substantial surge in need for Tirzepatide APIs. This potent medication, used to treat glucose intolerance, has attracted extensive attention from both individuals and doctors. As a result, numerous manufacturers have emerged as producers of Tirzepatide APIs in the USA. Well-known